QualityAs one of the nation’s leading referral, treatment, educational and research programs, the Brain Tumor Center at Cedars-Sinai is dedicated to providing leading-edge care and the best possible outcome for every patient.
Cedars-Sinai belongs to the University HealthSystem Consortium, which represents about 90 percent of the nation’s non-profit academic medical centers. The consortium fosters collaboration and assists in measuring and improving clinical, operational and financial performance. As part of the consortium, Cedars-Sinai maintains and shares outcomes data on mortality, length of stay and many other factors that reflect quality of care – statistics that compare favorably with other comparable top-tier programs.
In addition, the Brain Tumor Center has instituted an internal quality-assurance program that details every brain tumor patient’s outcome, including quality of life, survival, clinical symptoms, MRI findings and other pertinent statistics.
Cedars-Sinai is ranked among the nation's leaders for Neurology and Neurosurgical services in U.S. News and World Report's annual list of America's Best Hospitals. This prestigious list takes a variety of data, including key outcome measures, into consideration.